FORMULARY DECISION
Lisdexamfetamine : Elvanse
863/13 : As part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years of age and over when response to previous methylphenidate treatment...
We have found 2 results when searching "Lisdexamfetamine"
863/13 : As part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years of age and over when response to previous methylphenidate treatment...
1079/15 : Indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in adults.